
A significant drop in mergers that trigger antitrust reviews renders moot any calls by Democratic lawmakers to ban all mergers during the coronavirus pandemic, a Republican Federal Trade Commissioner said.
Mergers that require review either by the FTC or the Justice Department “have dropped off precipitously,” by roughly two-thirds since the start of the pandemic, Commissioner Christine Wilson said Monday during a conference hosted by the Federalist Society. As a result, any proposal to ban mergers completely should be dismissed, she said.
According to Bloomberg Law, in April, Reps. David Cicilline (D-R.I.) and Alexandria Ocasio-Cortez (D-N.Y.) and Sen. Elizabeth Warren (D-Mass.) proposed a ban on all corporate mergers during the pandemic. They expressed concern that dominant technology companies and private equity groups in particular are poised to engage in a buying spree leading to further industry consolidation.
The proposal, considered a long-shot effort, failed to make it into the latest coronavirus relief package proposed by House Democrats May 12.
Representatives for Ocasio-Cortez and Warren didn’t immediately respond to a request for comment.
In a statement to Bloomberg Law, Cicilline said that permitting dominant companies and private equity funds to engage in M&A activity during the pandemic “would be detrimental to the vast majority of Americans.”
“You hear some whining about how the sky will fall if we do a merger moratorium, but the truth is that the only people who lose from pressing pause on big mergers are top executives, bankers, and corporate lawyers,” Cicilline said.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas